Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Ryuki KIN"'
Autor:
Takakazu AOKI, Yoshio MATSUBARA, Hiroko SAGARA, Isao TOMIZAWA, Yoshihiko TAKIZAWA, Yoshirou NITTA, Takehisa SEO, Makoto KAMIMURA, Gohta MASUDA, Masayoshi NEGISHI, Shinten YO, Yatsuka IMAGAWA, Kenji OHNISHI, Kazue SAKU, Nagayo SHIMIZU, Tsuyoshi YAMAGUCHI, Masachika TSUJI, Jun-ichro HOSOYA, Jyuji HOSHINO, Fukiko AMANO, Chie NAKAMURA, Akira MURAMOTO, Yoshio KOBAYASHI, Ryuki KIN, Chihiro IMAI, Mitsuru AKAO, Akio TODO, Katsuhiko FUJIMI, Tadakazu AISAKA, Masanobu NIIMI, Toshiko MATSUO, Makoto SAITO, Rintaro NAKAYA, Nobuichi GOTO, Sankichi HORIUCHI, Yoshio INAGAKI, Hideko TAKANO
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 63:593-605
For the purpose of evaluation of clinical efficacy, safety and usefulness on acute infectious enteritis (bacillary dysentery, and enteritis caused by Salmonella spp., Campylobacter spp., enteropathogenic E. coli, and so on), T-3262, a newly developed
Autor:
Yoshiharu Yamamura, Shigeru Sugino, Mari Tanigawa, Hajime Sano, Motoharu Kondo, Haruki Kato, Ryuki Kin
Publikováno v:
Japanese Journal of Clinical Immunology. 11:121-127
マウス腹腔にPSKを投与して誘導される好中球の腫瘍増殖抑制作用を3H-thymidine, 3H-uridine取り込み抑制でみる腫瘍細胞のDNA, RNA合成阻害の面から検討した.CDF1マウスにPSK 50mg/kgを腹腔内注射す
Autor:
Ryuki Kin, Mari Tanigawa, Motoharu Kondo, Toshikazu Yoshikawa, Yoriko Kondo, Shigeru Sugino, Haruki Kato, Masahiro Ueda
Publikováno v:
Japanese Journal of Clinical Immunology. 9:74-80
It is experimentally known that antioxidants such as vitamin E (VE), selenium or ascorbic acid prevent chemical carcinogenesis in animals. Inhibitory effect of tumor growth was also reported by administration of VE into mouse whose serum level was ma
Publikováno v:
Chemotherapy. 32:113-117
The influence of normal human serum on bactericidal activity of ceftizoxime sodium (CZX) was studied in vitro against Escherichia coli and Staphylococcus aureus. Subminimal inhibitory concentrations of CZX inhibited the growth of bacteria. Normal hum
Autor:
Norimasa Yoshida, Masahiro Ueda, Toru Tanigawa, Toshikazu Yoshikawa, Shigeru Sugino, Shuhei Takemura, Mari Tanigawa, Motoharu Kondo, Haruki Kato, Ryuki Kin
Publikováno v:
Japanese Journal of Clinical Immunology. 10:586-593
Complement hemolytic activity (CH 50) in the sera from patients with malignancies has been reported to increase with the progression of the disease. However, C_??_ inhibitor (C_??_INH) and other protease inhibitors also increase in such conditions. I
Autor:
Takakazu AOKI, Nagayo SHIMIZU, Isao TOMIZAWA, Yoshihiko TAKIZAWA, Yoshio MATSUBARA, Takehisa SEO, Hiroko SAGARA, Keiko TAGAWA, Gohta MASUDA, Masayoshi NEGISHI, Chenden YOUNG, Yatsuka IMAGAWA, Misako MURATA, Tsuyoshi YAMAGUCHI, Masachika TSUJI, Jun-ichiro HOSOYA, Ippei FUJIMORI, Yoshio KOBAYASHI, Jyuji HOSHINO, Fukiko AMANO, Chie NAKAMURA, Akira MURAMOTO, Chihiro IMAI, Ryuki KIN, Mitsuru AKAO, Okisuke TSUNODA, Akio TODO, Katsuhiko FUJIMI, Akihiro HIRASA, Kan HASEGAWA, Tadakazu AISAKA, Masanobu NIIMI, Masao TAKEMOTO, Motoko MIKAMI, Toshiko MATSUO, Makoto SAITO, Rintaro NAKAYA, Nobuichi GOTO, Sankichi HORIUCHI, Noboru OKAMURA, Yoshio INAGAKI, Kayoko OZAWA, Yoshifumi TAKEDA
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 61:830-848
The clinical efficacy, safety and usefulness of lomefloxacin (LFLX, NY-198), a new quinolone antimicrobial agent, were compared with those of pipemidic acid (PPA) in the treatment of infectious enteritis (bacillary dysentery, enteropathogenic Escheri
Autor:
Hiroshi HASHIMOTO, Hiroko SAGARA, Yoshio MATSUBARA, Isao TOMIZAWA, Yoshihiko TAKIZAWA, Katsumi ITO, Kazumi KONISHI, Masami MATSUNAGA, Tokuo YANAGISHITA, Machi KOSUGI, Machiko TSUKADA, Takehisa SEO, Kazutsugu NIWANO, Isao YAMAWAKI, Gohta Masuda, Masayoshi NEGISHI, Yatsuka IMAGAWA, Misako MURATA, Toshie FUKAMI, Makoto SAITO, Nagayo SHIMIZU, Tsuyoshi YAMAGUCHI, Masachika TSUJI, Jun-ichiro HOSOYA, Ippei FUJIMORI, Yoshio KOBAYASHI, Jyuji HOSHINO, Fukiko AMANO, Kouji KATOU, Chie NAKAMURA, Akira MURAMOTO, Chihiro IMAI, Ryuki KIN, Mitsuru AKAO, Yorihiro SAKAUE, Shinichi KODA, Okisuke TSUNODA, Akio TODO, Tadakazu AISAKA, Masanobu NIIMI, Toshiko MATSUO, Shun-ichi SUGINO, Rintaro NAKAYA, Nobuichi GOTO, Sankichi HORIUCHI, Noboru OKAMURA, Toshio CHIDA, Harumi TOMEOKU, Kiyoshi HASEGAWA, Hideo NORIKI
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 58:1114-1134
Autor:
Takakazu AOKI, Yoshio MATSUBARA, Hiroko SAGARA, Nagayo SHIMIZU, Isao TOMIZAWA, Yoshihiko TAKIZAWA, Yoshirou NITTA, Takehisa SEO, Makoto KAMIMURA, Naoko KANEHISA, Gohta MASUDA, Masayoshi NEGISHI, Shinten YO, Yatsuka IMAGAWA, Kenji OHNISHI, Kazue SAKU, Tsuyoshi YAMAGUCHI, Masachika TSUJI, Jun-ichiro HOSOYA, Jyuji HOSHINO, Fukiko AMANO, Chie NAKAMURA, Akira MURAMOTO, Yoshio KOBAYASHI, Ryuki KIN, Chihiro IMAI, Mitsuru AKAO, Akio TODO, Katsuhiko FUJIMI, Tadakazu AISAKA, Masanobu NIIMI, Toshiko MATUO, Makoto SAITO, Rintaro NAKAYA, Nobuichi GOTO, Sankichi HORIUCHI, Yoshio INAGAKI, Hideko TAKANO
Publikováno v:
Journal of the Japanese Association for Infectious Diseases. 63:659-675
For the purpose of evaluation of clinical efficacy, safety and usefulness on Salmonella enteritis, T-3262 (Tosufloxacin tosilate), a newly developed pyridone-carboxylic acid derivative, was administered to a total of 103 patients and carriers. In add
Autor:
Mari Tanigawa, Motoharu Kondo, Haruki Kato, Yoshiharu Yamamura, Hajime Sano, Ryuki Kin, Shigeru Sugino
Publikováno v:
Japanese Journal of Clinical Immunology. 9:542-546
Anti-tumor effect of neutrophil migrating into peritoneal or pleural cavity was demonstrated in patients with carcinomatous peritonitis or pleuritis by the intraperitoneal or intrapleural injection of OK-432. Complement-derived chemotactic factor suc
Autor:
Haruki Kato, Motoharu Kondo, Norimasa Yoshida, Masashi Murakami, Ryuki Kin, Toshikazu Yoshikawa, Nobuyoshi Yokoe, Shigeru Sugino, Osamu Seto
Publikováno v:
Japanese Journal of Clinical Immunology. 8:214-217
OK-432, one of the so-called biological response modifiers (BRMs), has been reported to restore cellular and humoral immune responses in tumor-bearing individuals. However, since host immune responses in tumor-bearing individuals are modified by deve